Introduction
============

Tuberculosis (TB) is a chronic, necrotizing disease caused by the *Mycobacterium tuberculosis* complex that primarily affects the lungs. It is transmitted through droplet nuclei that are aerosolized by coughing, sneezing, or speaking.[@b1-rrtm-8-065] Globally, in 2010, there were 8.8 million incident cases of TB and 1.1 million deaths from TB among HIV-negative people with an additional 0.35 million deaths from HIV-associated TB. Most of the estimated number of cases occurred in Asia (59%) and Africa (26%). Regarding regions of World Health Organization (WHO), the mortality rate was higher in Africa followed by Southeast Asian regions.[@b2-rrtm-8-065]

Ethiopia, ranked ninth among the world's 22 TB high burden countries, has been given the highest priority at the global level since 2000.[@b2-rrtm-8-065] The statistical data of Ethiopian Federal Ministry of Health hospitals have shown that TB is the leading cause of morbidity, the third cause of hospital admissions (after deliveries and malaria), and the second cause of death in Ethiopia next to malaria.[@b3-rrtm-8-065]

The specific target of Directly Observed Treatment, Short-course (DOTS) detailed in the updated Global Plan (2011--2015) was to achieve a treatment success rate (TSR) of 87% by 2015.[@b4-rrtm-8-065]

During the intensive phase (first 2 months), the patients must collect the drugs daily and should take the medicine under the direct observation of a health worker. First-line treatment of TB in Ethiopia includes rifampicin, ethambutol, isoniazid, pyrazinamide, and streptomycin.[@b3-rrtm-8-065]

Globally, in the 2009 cohort, TSR for the 2.6 million new cases of sputum smear-positive pulmonary TB was 87%. However, in the African region, one of the regions that did not meet the target, TSR was 81% despite its steady improvement since 1997.[@b2-rrtm-8-065]

Ethiopia did not achieve the goal until 2009. In Ethiopia, the National Tuberculosis and Leprosy Control Programme introduced the DOTS strategy in 1995. Despite reaching full coverage in 2005, TSR was only 84% in 2009.[@b2-rrtm-8-065]

Despite the global efforts to combat TB, the low TSR in Africa, especially in the sub-Saharan countries like Ethiopia, is intrinsically related to non-completion of treatment due to several factors, especially death and default.[@b5-rrtm-8-065],[@b6-rrtm-8-065]

The sociodemographic and economic status of TB patients has an impact on TB treatment outcomes. Studies showed that men were more likely to have a poor treatment outcome than women.[@b7-rrtm-8-065]--[@b12-rrtm-8-065] In addition, age (40+ years) was a risk factor for unsuccessful TB treatment outcome.[@b10-rrtm-8-065],[@b13-rrtm-8-065]--[@b16-rrtm-8-065] Also, low educational level was a risk factor for not to be cured[@b17-rrtm-8-065] and being default.[@b18-rrtm-8-065] Similarly, unemployment was a risk factor for unsuccessful treatment outcome.[@b13-rrtm-8-065]

On the other hand, previous studies[@b10-rrtm-8-065],[@b14-rrtm-8-065],[@b15-rrtm-8-065] evidenced that treatment compliance was a major factor for TB treatment outcomes. History of default was a significant factor to have unsuccessful treatment outcome.[@b10-rrtm-8-065],[@b14-rrtm-8-065],[@b15-rrtm-8-065] In addition, patients who were on retreatment were more susceptible for poor TB treatment outcomes.[@b16-rrtm-8-065],[@b17-rrtm-8-065],[@b19-rrtm-8-065]

Furthermore, subsequent hospitalization, comorbidity (HIV, liver disease, lung cancer, and others),[@b7-rrtm-8-065],[@b12-rrtm-8-065],[@b16-rrtm-8-065]--[@b18-rrtm-8-065] having a treatment observer,[@b17-rrtm-8-065] having a positive smear at the second-month follow-up, and having smear-negative pulmonary TB,[@b14-rrtm-8-065] and family size[@b13-rrtm-8-065] were identified as significant factors for unsuccessful TB treatment outcomes.

Therefore, this study focused on investigating the status of TB treatment outcome rate and associated risk factors in North Shoa Administrative Zone, Amhara Regional State, Ethiopia.

Materials and methods
=====================

Study design and population
---------------------------

A retrospective cohort study design was used to conduct this study. The study population was all TB patients who were treated for TB in the public hospitals in North Shoa Administrative Zone from September 1, 2012 to August 31, 2014. This study included all TB-treated patients who had a complete document at the public hospitals in North Shoa Administrative Zone, Amhara Regional State, Ethiopia. The capital city of North Shoa Administrative Zone, Debre Berhan, is located on the northeastern part of Ethiopia, which is 130 km away from the capital city of Ethiopia, Addis Ababa. The population of North Shoa Administrative Zone was estimated to be 2.02 million.

Sampling procedure, data collection tools, and procedure
--------------------------------------------------------

A retrospective assessment of the profile and treatment outcomes of all TB patients (739) who registered from September 1, 2012 to August 31, 2014 at the DOTS clinic in three public hospitals was conducted.

The data were collected from patients' routine records, including basic clinical and demographic information, directly observed therapy provider type, history of previous treatment, treatment adherence, adverse reactions, and retrieval actions. The data were gathered by using a pretested structured medical records checklist, which was adopted from previous literature.[@b3-rrtm-8-065],[@b10-rrtm-8-065],[@b13-rrtm-8-065],[@b19-rrtm-8-065] The data were collected by four trained BSc senior healthcare providers and two trained Masters of Public Health (MPH) supervisors. The field record checklists were checked on a daily basis for completeness.

Data processing and analysis
----------------------------

The collected data were coded and double entered into Epi Info and were analyzed by using the SPSS software packege version 20. Descriptive statistics was used to present the different characteristics of the study variables. Odds ratio (OR) and 95% confidence interval (CI) were calculated by using the multivariate logistic regression analysis to identify the independent risk factors for TB treatment outcomes (success or failure). The variables were included in the multivariate analysis when the *P*-values were \<0.2 in the bivariate analysis. *P*-values \<0.05 were considered as statistically significant.

Ethical consideration
---------------------

This study was approved by the research review committee of College of Medicine and Health Sciences, Debre Berhan University. Permission to conduct the study was obtained from Debre Berhan Referral Hospital (DBRH), Mehal Meda Hospital, and Ataye Hospital. During document review, codes were used and anonymity was assured. According to the research review committee of College of Medicine and Health Sciences, written consent was not required as confidentiality and anonymity were strictly maintained. The study could cause no harm to the study participants.

Results
=======

Sociodemographic characteristics of the respondents
---------------------------------------------------

A total of 739 patients who were treated for TB at the three public hospitals (Ataye, Debre Berhan, and Mehal Meda) were included in this study. More than half of the study participants were male, married, and urban residents (398\[53.9%\], 415 \[56.1%\], and 439 \[59.4%\], respectively). Majority of the study participants were orthodox and unemployed (638 \[86.3%\] and 531 \[71.9%\], respectively) ([Table 1](#t1-rrtm-8-065){ref-type="table"}).

TB disease-related conditions of patients
-----------------------------------------

Of the 739 study participants, 430 (58.2%) and 309 (41.8%) were patients who were treated for TB at the period of September 2012 to August 2014 respectively. In addition, 349 (47.2%) of the study participants were from DBRH. Four hundred and ninety-five (67%) of the patients were smear negative at treatment initiation and pulmonary TB accounts 598 (80.9%), (sputum smear positive \[SS+\] 214 \[29%\] and 368 \[49.8%\]), of the study participants. Extra pulmonary TB account 129 (17.5%) includes lymph system, pleura, bone/spine/joint, disseminated, abdominal, and pericardiac. Only 19 (2.6%) of the study participants had a positive smear test at second months of the treatment ([Table 2](#t2-rrtm-8-065){ref-type="table"}).

HIV/antiretroviral therapy (ART), substance use, and other related characteristics of patients
----------------------------------------------------------------------------------------------

One hundred and fifty-five (21%) of the study participants were HIV positive, of which 99 (63.9%) were taking ART. According to the findings of this study, 46 (6.1%) of the study participants were subsequently hospitalized. On the other hand, 728 (98.5%) participants had a supporter when they were taking anti-TB treatment. Concerning substance use, only 11 (1.5%), 61 (8.3%), and 40 (5.4%) were smokers, khat chewers, and alcohol drinkers, respectively ([Table 3](#t3-rrtm-8-065){ref-type="table"}).

TB treatment outcome, defaulting, and drug side effects
-------------------------------------------------------

According to this study, 636 (86.1%) of the study participants completed the TB treatment successfully. Among these, 169 (22.9%) were cured and 467 (63.2%) completed. Concerning the history of treatment defaulting, 22 (3%) participants defaulted. Majority of them (19 \[2.6%\]) interrupted during the intensive phase. In addition, 554 (75%) had a history of treatment compliance. Ten (1.4%) participants had severe drug side effects during the TB treatment ([Table 4](#t4-rrtm-8-065){ref-type="table"}).

Factors associated with TB treatment outcome
--------------------------------------------

To note the effect of independent variables on the dependent variable (TB treatment outcomes), the bivariate logistic regression analysis was carried out. The crude analysis included sociodemographic variables, year of TB treatment, TB disease-related variables, HIV and ART status, treatment compliance, defaulting, and other related variables.

On the bivariate analysis, year of treatment, TB contracting history, TB type or disease classification, sputum smear positivity at the second-month follow-up, HIV status, ART status, history of treatment default, and subsequent hospitalization had a significant association with TB treatment outcome. The variables with *P*-value \<0.2 in the bivariate analysis were included in the multivariate logistic regression analysis to control the confounding effect of the different variables on the dependent variables.

The multivariate analysis was employed to assess the net effect of the variables. The results of multiple logistic regression model revealed that the year of treatment, sputum smear positivity at the second-month follow-up, history of treatment default, and subsequent hospitalization were significantly associated with the TB treatment outcome ([Table 5](#t5-rrtm-8-065){ref-type="table"}).

Discussion
==========

This study revealed that TB TSR for the period of September 2012--August 2014 at the public hospitals of North Shoa Administrative Zone, Amhara Regional State, Ethiopia, was 86.1% (169 \[22.9%\] cured and 467 \[63.2%\] completed). This finding is not in line with the WHO updated Global Plan to Stop TB (2011--2015).[@b4-rrtm-8-065] This study's finding was also lower than the study finding in Enfraz Health Center, Northwest Ethiopia, which was 94.8%.[@b19-rrtm-8-065] But, TSR of this study was similar to another study finding in Northwest Ethiopia, which was (85.6%),[@b20-rrtm-8-065] and higher than that in Nigeria, which was (76.6%).[@b9-rrtm-8-065] This difference could be due to the time gap between the studies that had been conducted and the sociodemographic differences.

With regard to the history of treatment defaulting, 22 (3%) of the study participants defaulted. Majority of them (19 \[2.6%\]) interrupted during the intensive phase. This study's finding was higher than the study finding in Northwest Ethiopia at Enfraz Health Center, which was (1.2%),[@b19-rrtm-8-065] but it was lower than another study finding in Dembia District, Northwest Ethiopia, which was 3.5%.[@b20-rrtm-8-065]

In this study, the death rate was 3.5%, which was similar to the study finding in Northwest Ethiopia at Enfraz Health Center and Dembia District, which were 3.4% and 3.3%, respectively.[@b19-rrtm-8-065],[@b20-rrtm-8-065] But, this study's finding was higher than the study finding in Ibadan, Nigeria, (1.9%).[@b9-rrtm-8-065] The TB treatment failure rate of this study was 0.8%, which was higher than the study finding in Northwest Ethiopia at Enfraz Health Center (0.5%)[@b19-rrtm-8-065] and was lower than the study finding in Ibadan, Nigeria, (8.1%).[@b9-rrtm-8-065] Those differences in TB treatment outcome could be due to different study periods, geographical differences, or sociodemographic and economic conditions. Besides, the effort of the urban and rural health extension workers in the follow-up of these TB patients in their working areas had its own effect on those differences.

In general, the multiple logistic regression model revealed that the year of treatment, sputum smear positivity at the second-month follow-up, history of treatment default, and subsequent hospitalization were significantly associated with the TB treatment outcome.

Those TB patients who were treated from September 2013 to August 2014 were 3.7 times more likely to be successful than those TB patients who were treated from September 2012 to August 2013 (adjusted OR \[AOR\], 3.723; 95% CI, 2.022--6.857). This might be due to the low default rate and some improvement in the healthcare system and use of technologies like mobile phones for communication.

This study revealed that those TB patients who had no history of treatment default were \~82 times more likely to be successfully treated than those who had a history of anti-TB treatment default (AOR, 81.98; 95% CI, 20.49--327.99). This is in line with the findings of studies in Northeastern Thailand, Brazilian Amazon, and Nairobi, Kenya.[@b12-rrtm-8-065],[@b16-rrtm-8-065],[@b18-rrtm-8-065] This high odds ratio with a *P*-value of \<0.0001 indicates that there is a strong association between anti-TB treatment default and its outcomes, because defaulting the anti-TB treatment may decrease the effectiveness of drugs and develop the resistance by *M. tuberculosis* in the patients.

The study also revealed that the TB patients who had no history of subsequent hospitalization were 6 times more likely to be successfully treated than those who had a history of subsequent hospitalization (AOR, 6.072; 95% CI, 2.77--13.33). This might be due to the root reasons for the subsequent hospitalization which those patients subsequently hospitalized during the anti-TB treatment. But, they may have other medical problems and their treatment compliance is under question.

This study also identified that those TB patients who had a negative smear at the second-month follow-up were about 9 times more likely to be successfully treated for TB than those who had smear-positive pulmonary TB (AOR, 8.812; 95% CI, 2.836--27.379). This finding is similar to the finding of the study conducted in the southern region of Ethiopia.[@b14-rrtm-8-065] This indicates that the anti-TB treatment is more effective in treating those patients who had negative smear at the second-month follow-up.

In this study, age of patients, educational status, occupational status, TB type/classification, side effects of drug, TB--HIV coinfection, and ART status were not statistically significantly associated with the anti TB treatment outcomes. Similarly the study conducted in the Tigray Region among pulmonary TB patients showed that the TB treatment outcomes had no statistically significant association with the HIV status among the TB patients. What is more is, it is not statistical significant with the TB treatment success where 88.1% and 78.1% on HIV negative and positive TB patients respectively. The poor outcome among HIV--TB coinfected patients could be due to the inadequate immune response to control the infection and delay in diagnosis and getting treatment.[@b21-rrtm-8-065],[@b22-rrtm-8-065]

Conclusion
==========

TB TSR in North Shoa Administrative Zone was low. The default rate specifically in the intensive phase of the TB treatment (the first 2 months), on which the DOTS program was implemented, was the main reason for low TB treatment outcomes. The variables such as year of treatment, sputum smear positivity at the second-month follow-up, history of treatment default, and subsequent hospitalization were significantly associated with the TB treatment outcome. To improve TB TSR, it is required to enhance supportive supervision and monitoring mechanisms, counsel during the intensive and continual phases of treatment, strengthen home visits (defaulter tracing), and motivate patients and their supporters through providing health education to reduce treatment interruption. Moreover, further studies, using a prospective study design, focusing on the molecular structure of TB bacillus, which may be responsible for the TB treatment outcomes, in addition to the sociodemographic, environmental, psychosocial, and physiological variables are warranted.

Limitations
===========

The source of information for this study was secondary data from TB logbook and other routine medical records of the patients. Incomplete data and some missing variables like infected strain or genotypes of TB bacillus, lack of knowledge about treatment, annual income, and distance to travel to get treatment were the limitations during document review.
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###### 

Sociodemographic characteristics of tuberculosis patients who were treated from September 2012 to August 2014 at public hospitals of North Shoa Zone, Amhara Regional State, Ethiopia

  Variable                     Category                Frequency (N)   Percentage
  ---------------------------- ----------------------- --------------- ------------
  **Sex**                      Male                    398             53.9
  Female                       341                     46.1            
  **Age (years)**              ≤20                     158             21.4
  21--30                       223                     30.2            
  31--40                       125                     16.9            
  41+                          233                     31.5            
  **Marital status**           Single                  268             36.3
  Married                      415                     56.1            
  Divorced                     45                      6.1             
  Widowed                      11                      1.5             
  **Ethnicity**                Amhara                  670             90.7
  Oromo                        64                      8.7             
  Other                        5                       0.7             
  **Residence**                Urban                   439             59.4
  Rural                        300                     40.6            
  **Educational status**       Cannot read and write   117             15.8
  Read and write, not formal   68                      9.2             
  1--8 elementary              113                     15.3            
  Secondary and above          106                     14.3            
  **Occupation**               Not known               335             45.3
  Employed                     208                     28.1            
  Unemployed                   531                     71.9            
  **Religion**                 Orthodox                638             86.3
  Muslim                       89                      12.0            
  Other                        12                      1.7             
  **Family size**              One                     106             14.3
  Two                          214                     29.0            
  Three                        170                     23.0            
  Four or more                 249                     33.7            

###### 

TB-disease related conditions of patients who were treated from September 2012 to August 2014 in North Shoa Zone, Amhara Regional State, Ethiopia

  Variables                                                   Category                         Frequency (N)   Percentage
  ----------------------------------------------------------- -------------------------------- --------------- ------------
  **Year of treatment initiation**                            2006                             430             58.2
  2007                                                        309                              41.8            
  **Health facility name**                                    Debre Berhan Referral Hospital   349             47.2
  Ataye Hospital                                              220                              29.8            
  Mehal Meda Hospital                                         170                              23.0            
  **Sputum smear result at treatment initiation**             Smear negative                   495             67.0
  Smear positive                                              227                              30.7            
  Not known                                                   17                               2.3             
  **TB contracted history**                                   Present                          50              6.8
  Absent                                                      309                              41.8            
  Missed                                                      380                              51.4            
  **TB type or disease classification**                       EPTB                             129             17.5
  PTB                                                         598                              80.9            
  Not known                                                   12                               1.6             
  **Type of PTB**                                             SS+                              214             29.0
  SS−                                                         368                              49.8            
  Not known                                                   157                              21.2            
  **Site of EPTB**                                            Lymph system                     70              9.5
  Pleural                                                     15                               2.0             
  Bone/spine/joint                                            21                               2.8             
  Disseminated                                                18                               2.4             
  Abdominal                                                   8                                1.1             
  Pericardiac                                                 11                               1.5             
  **Sputum smear positivity at the second-month follow-up**   Yes                              19              2.6
  No                                                          694                              93.9            
  Not known                                                   26                               3.5             

**Abbreviations:** TB, tuberculosis; EPTB extra pulmonary tuberculosis; PTB, pulmonary tuberculosis; SS+, sputum smear positive; SS−, sputum smear negative.

###### 

HIV/ART, substance use, and other related characteristics of patients who were treated for TB from September 2012 to August 2014 in North Shoa Zone, Amhara Regional State, Ethiopia

  Variables                                       Category   Frequency (N)   Percentage
  ----------------------------------------------- ---------- --------------- ------------
  **HIV status**                                  Positive   155             21.0
  Negative                                        584        79.0            
  **ART status**                                  No         584             79.0
  CPT                                             26         3.5             
  ART                                             99         13.4            
  Pre-ART                                         30         4.1             
  **Subsequent hospitalization**                  Yes        46              6.2
  No                                              693        93.8            
  **Availability of supporter**                   Yes        728             98.5
  No                                              11         1.5             
  **Cigarette smoking on treatment initiation**   Yes        11              1.5
  No                                              728        98.5            
  **Khat chewing on treatment initiation**        Yes        61              8.3
  No                                              678        91.7            
  **Alcohol use on treatment initiation**         Yes        40              5.4
  No                                              699        94.6            

**Abbreviations:** ART, antiretroviral therapy; TB, tuberculosis; CPT, co-trimoxazole preventive therapy.

###### 

TB treatment outcome, defaulting, and drug side effects of patients who were treated from September 2012 to August 2014 in North Shoa Zone, Amhara Regional State, Ethiopia

  Variables                                                             Category          Frequency (N)   Percentage
  --------------------------------------------------------------------- ----------------- --------------- ------------
  **TB treatment outcome**                                              Succeeded         636             86.1
  Failed                                                                103               13.9            
  **TB treatment outcome detail**                                       Cured             169             22.9
  Treatment completed                                                   467               63.2            
  Defaulted                                                             22                2.98            
  Failed                                                                6                 0.8             
  Died                                                                  28                3.8             
  Transferred in                                                        7                 0.9             
  Transferred out                                                       28                3.8             
  Not known                                                             12                1.6             
  **History of default on treatment**                                   Yes               22              3.0
  No                                                                    717               97.0            
  **Defaulted in terms of phase**                                       Intensive phase   19              2.6
  Continuation phase                                                    10                1.4             
  No interruption                                                       702               95.0            
  Not known                                                             8                 1.1             
  **Compliance on duration of treatment**                               Yes               554             75.0
  No                                                                    185               25.0            
  **Occurrence of severe drug side effects during TB treatment time**   Yes               10              1.4
  No                                                                    729               98.6            

**Abbreviation:** TB, tuberculosis.

###### 

Factors associated with TB treatment outcome among patients who were treated from September 2012 to August 2014 at public hospitals in North Shoa Zone, Amhara Regional State, Ethiopia

  Variables                                               TB treatment outcome   Crude OR (95% CI)   Adjusted OR (95% CI)                                                   
  ------------------------------------------------------- ---------------------- ------------------- ---------------------------------------------------------------------- ----------------------------------------------------------------------
  Time of treatment                                                                                                                                                         
   September 2012--August 2013                            347                    83                  1                                                                      1
   September 2013--August 2014                            289                    20                  3.456 (2.070--5.771)[\*\*\*](#tfn7-rrtm-8-065){ref-type="table-fn"}    3.723 (2.022--6.857)[\*\*\*](#tfn7-rrtm-8-065){ref-type="table-fn"}
  TB type                                                                                                                                                                   
   EPTB                                                   118                    11                  1                                                                      
   PTB                                                    517                    81                  0.595 (0.31--1.152)                                                    
   Not known                                              1                      11                  0.008 (0.001--0.072)[\*\*\*](#tfn7-rrtm-8-065){ref-type="table-fn"}    
  Sputum smear positivity at the second-month follow-up                                                                                                                     
   Yes                                                    13                     6                   1                                                                      1
   No                                                     613                    81                  3.493 (1.292--9.444)[\*\*](#tfn6-rrtm-8-065){ref-type="table-fn"}      8.812 (2.836--27.379)[\*\*\*](#tfn7-rrtm-8-065){ref-type="table-fn"}
   Not known                                              10                     16                  0.288 (0.083--1.006)                                                   1.024 (0.222--4.719)
  HIV status                                                                                                                                                                
   Positive                                               121                    34                  1                                                                      
   Negative                                               515                    69                  2.1 (1.33--3.31)[\*\*](#tfn6-rrtm-8-065){ref-type="table-fn"}          
  ART status                                                                                                                                                                
   Not HIV+                                               516                    68                  8.67 (4.05--18.55)[\*\*\*](#tfn7-rrtm-8-065){ref-type="table-fn"}      
   CPT                                                    20                     6                   3.81 (1.19--12.16)[\*](#tfn5-rrtm-8-065){ref-type="table-fn"}          
   ART                                                    86                     13                  7.56 (3.0--19.06)[\*\*\*](#tfn7-rrtm-8-065){ref-type="table-fn"}       
   Pre-ART                                                14                     16                  1                                                                      
  History of treatment default                                                                                                                                              
   Yes                                                    3                      19                  1                                                                      1
   No                                                     633                    84                  47.73 (13.83--164.72)[\*\*\*](#tfn7-rrtm-8-065){ref-type="table-fn"}   81.98 (20.49--327.99)[\*\*\*](#tfn7-rrtm-8-065){ref-type="table-fn"}
  Subsequent hospitalization                                                                                                                                                
   Yes                                                    30                     16                  1                                                                      1
   No                                                     606                    87                  3.72 (1.95--7.10)[\*\*\*](#tfn7-rrtm-8-065){ref-type="table-fn"}       6.072 (2.77--13.33)[\*\*\*](#tfn7-rrtm-8-065){ref-type="table-fn"}

**Notes:** Hosmer--Lemeshow test *P*-value =0.956.

*P*\<0.05,

*P*\<0.01, and

*P*\<0.001.

**Abbreviations:** ART, antiretroviral therapy; CI, confidence interval; OR, odds ratio; TB, tuberculosis; EPTB extra pulmonary tuberculosis; PTB, pulmonary tuberculosis; CPT, co-trimoxazole preventive therapy.
